PDF herunterladen
Am J Perinatol 2025; 42(07): 834-841
DOI: 10.1055/a-2419-9404
SMFM Fellowship Series Article

Utility of Reticulocyte Hemoglobin Equivalent in Screening for Iron Deficiency in Pregnancy

Lylach Haizler-Cohen 
1   Department of Obstetrics and Gynecology, MedStar Washington Hospital Center, Washington, District of Columbia
,
Haleema Saeed
1   Department of Obstetrics and Gynecology, MedStar Washington Hospital Center, Washington, District of Columbia
,
Valencia Quiett
2   Bloodless Medicine and Surgery Program, MedStar Georgetown University Hospital, Washington, District of Columbia
,
Gurpinder Kaur
1   Department of Obstetrics and Gynecology, MedStar Washington Hospital Center, Washington, District of Columbia
,
Eshetu A. Tefera
3   Department of Biostatistics, MedStar Health Research Institute, Hyattsville, Maryland
,
Samrawit Gizaw
3   Department of Biostatistics, MedStar Health Research Institute, Hyattsville, Maryland
,
Richard Verstraete
2   Bloodless Medicine and Surgery Program, MedStar Georgetown University Hospital, Washington, District of Columbia
,
Michael Auerbach
4   Department of Medicine, Georgetown University School of Medicine, Washington, District of Columbia
,
Nicholas Hazen
5   Department of Obstetrics and Gynecology, MedStar Georgetown University Hospital, Washington, District of Columbia
› Institutsangaben Funding The Medstar Health Graduate Medical Education helped support the laboratory testing and statistical analysis for this study.
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Objective

Ferritin, commonly used for diagnosing iron deficiency (ID) in pregnancy, is limited by high cost and false elevations during inflammation. Reticulocyte hemoglobin equivalent (Ret-He), an alternative marker for ID, is unaffected by inflammation and analyzed on the same collection tube as the standard complete blood count (CBC). We aimed to determine the accuracy of Ret-He in detecting ID in pregnancy compared to ferritin in a U.S. cohort.

Study Design

This prospective cohort study enrolled 200 pregnant participants, recruited in any trimester if a CBC was drawn as part of routine prenatal care. For those who agreed to participate, Ret-He and ferritin were collected concurrently with the CBC. ID was defined as ferritin level below 30 ng/mL. Patients were classified into three groups based on hemoglobin and ferritin results to determine the severity of ID: no ID, ID alone, and ID anemia (IDA). Four participants with anemia but normal ferritin were excluded. Receiver operating curve analysis, including the area under the curve (AUC), was performed to assess the accuracy of Ret-He in detecting ID. A one-way ANOVA (analysis of variance) with post-hoc analysis was used to compare differences in Ret-He between the three groups of ID severity.

Results

The prevalence of ID in our cohort was 82% (161/196). The AUC for Ret-He was 0.65 (95% confidence interval: 0.55–0.75), indicating suboptimal discrimination between patients with and without ID. Ret-He was significantly different among the three groups (p < 0.001). In post-hoc analysis, Ret-He was significantly lower in the IDA group compared to the ID group (p < 0.001) but there was only a trend of lower Ret-He in the ID group compared to the non-ID group (p = 0.38).

Conclusion

Ret-He has low accuracy in diagnosing ID in pregnancy. It may be useful in detecting severe ID resulting in anemia but not a mild iron-deficient state resulting in ID only.

Key Points

  • The prevalence of ID in our cohort was 82%.

  • Ret-He has low accuracy in diagnosing ID in pregnancy.

  • Ferritin is preferable when readily available.

Keywords

anemia - ferritin - iron deficiency - pregnancy - reticulocyte - reticulocyte hemoglobin equivalent

Note

The findings of this study were presented at the 44th Annual Pregnancy Meeting by the Society for Maternal Fetal Medicine, National Harbor, MD, February 10 to 14, 2024.




Publikationsverlauf

Eingereicht: 25. Mai 2024

Angenommen: 20. September 2024

Accepted Manuscript online:
24. September 2024

Artikel online veröffentlicht:
10. Oktober 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Gernand AD, Schulze KJ, Stewart CP, West Jr. KP, Christian P. Micronutrient deficiencies in pregnancy worldwide: health effects and prevention. Nat Rev Endocrinol 2016; 12 (05) 274-289
    CrossrefPubMedSuche in Google Scholar
  • 2 Iron Deficiency Anemia: assessment, prevention and control: a guide for programme managers. 2015 February 26th, 2024. Accessed October 1, 2024 at: https://cdn.who.int/media/docs/default-source/2021-dha-docs/ida_assessment_prevention_control.pdf?sfvrsn=fb8c459c_1&download=true
    PubMed
  • 3 Auerbach M, Abernathy J, Juul S, Short V, Derman R. Prevalence of iron deficiency in first trimester, nonanemic pregnant women. J Matern Fetal Neonatal Med 2021; 34 (06) 1002-1005
    CrossrefPubMedSuche in Google Scholar
  • 4 Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. MMWR Recomm Rep 1998; 47 (RR-3): 1-29
    PubMedSuche in Google Scholar
  • 5 Rasmussen K. Is there a causal relationship between iron deficiency or iron-deficiency anemia and weight at birth, length of gestation and perinatal mortality?. J Nutr 2001; 131 (2S-2): 590S-601S , discussion 601S–603S
    CrossrefPubMedSuche in Google Scholar
  • 6 Georgieff MK. Iron deficiency in pregnancy. Am J Obstet Gynecol 2020; 223 (04) 516-524
    CrossrefPubMedSuche in Google Scholar
  • 7 Rath CE, Finch CA. Sternal marrow hemosiderin; a method for the determination of available iron stores in man. J Lab Clin Med 1948; 33 (01) 81-86
    PubMedSuche in Google Scholar
  • 8 Camaschella C. Iron-deficiency anemia. N Engl J Med 2015; 372 (19) 1832-1843
    CrossrefPubMedSuche in Google Scholar
  • 9 Peace JM, Banayan JM. Anemia in pregnancy: pathophysiology, diagnosis, and treatment. Int Anesthesiol Clin 2021; 59 (03) 15-21
    CrossrefPubMedSuche in Google Scholar
  • 10 Mast AE, Blinder MA, Dietzen DJ. Reticulocyte hemoglobin content. Am J Hematol 2008; 83 (04) 307-310
    CrossrefPubMedSuche in Google Scholar
  • 11 Siddon AJ, Tormey CA. The chemical and laboratory investigation of hemolysis. Adv Clin Chem 2019; 89: 215-258
    CrossrefPubMedSuche in Google Scholar
  • 12 Sysmex. Accessed September 25, 2024 at: https://www.sysmex-europe.com/academy/knowledge-centre/technologies/reticulocyte-count-application-ret/
    PubMed
  • 13 Mast AE, Blinder MA, Lu Q, Flax S, Dietzen DJ. Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. Blood 2002; 99 (04) 1489-1491
    CrossrefPubMedSuche in Google Scholar
  • 14 Brugnara C, Zurakowski D, DiCanzio J, Boyd T, Platt O. Reticulocyte hemoglobin content to diagnose iron deficiency in children. JAMA 1999; 281 (23) 2225-2230
    CrossrefPubMedSuche in Google Scholar
  • 15 Urrechaga E, Borque L, Escanero JF. Clinical value of hypochromia markers in the detection of latent iron deficiency in nonanemic premenopausal women. J Clin Lab Anal 2016; 30 (05) 623-627
    CrossrefPubMedSuche in Google Scholar
  • 16 Anemia in Pregnancy. Anemia in pregnancy: ACOG Practice Bulletin, Number 233. Obstet Gynecol 2021; 138 (02) e55-e64
    CrossrefPubMedSuche in Google Scholar
  • 17 WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations [Internet]. Geneva: World Health Organization; 2020 . Accessed September 25, 2024 at: https://www.ncbi.nlm.nih.gov/books/NBK569880/
    PubMedSuche in Google Scholar
  • 18 Nahm FS. Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol 2022; 75 (01) 25-36
    CrossrefPubMedSuche in Google Scholar
  • 19 Bó SD, Fragoso ALR, Farias MG, Hubner DPG, de Castro SM. Evaluation of RET-He values as an early indicator of iron deficiency anemia in pregnant women. Hematol Transfus Cell Ther 2023; 45 (01) 52-57
    CrossrefPubMedSuche in Google Scholar
  • 20 Ervasti M, Kotisaari S, Heinonen S, Punnonen K. Use of advanced red blood cell and reticulocyte indices improves the accuracy in diagnosing iron deficiency in pregnant women at term. Eur J Haematol 2007; 79 (06) 539-545
    CrossrefPubMedSuche in Google Scholar
  • 21 Levy S, Schapkaitz E. The clinical utility of new reticulocyte and erythrocyte parameters on the Sysmex XN 9000 for iron deficiency in pregnant patients. Int J Lab Hematol 2018; 40 (06) 683-690
    CrossrefPubMedSuche in Google Scholar
  • 22 Kumar U, Chandra H, Gupta AK, Singh N, Chaturvedi J. Role of Reticulocyte parameters in anemia of first trimester pregnancy: a single center observational study. J Lab Physicians 2020; 12 (01) 15-19
    Thieme ConnectPubMedSuche in Google Scholar
  • 23 Mei Z, Addo OY, Jefferds MED, Flores-Ayala RC, Brittenham GM. Physiologically based trimester-specific serum ferritin thresholds for iron deficiency in US pregnant women. Blood Adv 2024; 8 (14) 3745-3753
    CrossrefPubMedSuche in Google Scholar
  • 24 Griffin MM, Avtushka V, Venkatesh P, Aquino J, Roman AS. Reticulocyte hemoglobin trend in pregnancy. Am J Obstet Gynecol 2023; 229 (04) 471-472
    CrossrefPubMedSuche in Google Scholar
  • 25 Suchdev PS, Williams AM, Mei Z. et al. Assessment of iron status in settings of inflammation: challenges and potential approaches. Am J Clin Nutr 2017; 106 (Suppl. 06) 1626S-1633S
    CrossrefPubMedSuche in Google Scholar
  • 26 Auerbach M, Staffa SJ, Brugnara C. Using reticulocyte hemoglobin equivalent as a marker for iron deficiency and responsiveness to iron therapy. Mayo Clin Proc 2021; 96 (06) 1510-1519
    CrossrefPubMedSuche in Google Scholar
  • 27 Blackwelder WC. “Proving the null hypothesis” in clinical trials. Control Clin Trials 1982; 3 (04) 345-353
    CrossrefPubMedSuche in Google Scholar